Rezurock and Zofran drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rezurock (belumosudil mesylate) and Zofran (ondansetron hydrochloride). Common drug interactions include fatigue among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Rezurock and Zofran. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.

What is Rezurock?

Rezurock has active ingredients of belumosudil mesylate. eHealthMe is studying from 1,132 Rezurock users. Check the latest studies of Rezurock.

What is Zofran?

Zofran has active ingredients of ondansetron hydrochloride. It is often used in nausea. eHealthMe is studying from 94,987 Zofran users. Check the latest studies of Zofran.

On Jul, 15, 2026

34 people who take Rezurock and Zofran together, and have interactions are studied.

What are the common drug interactions of Rezurock and Zofran, by gender? *:

female:

Fatigue (feeling of tiredness)
Diarrhoea
Headache (pain in head)
Insomnia (sleeplessness)
Pruritus (severe itching of the skin)
Dyspnoea (difficult or laboured respiration)
Rash
Blood creatinine increased
Blood immunoglobulin g decreased
Blood magnesium decreased

male:

Fatigue (feeling of tiredness)
Dry skin
Cough
Erythema (redness of the skin)
Haematocrit decreased
Haemoglobin decreased
Nasopharyngitis (inflammation of the nasopharynx)
Platelet count decreased
Protein total decreased
Red blood cell count decreased

What are the common drug interactions of Rezurock and Zofran, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Leukaemia recurrent (repeat cancer of bone marrow or blood cells)

30-39:

Cough
Alanine aminotransferase increased
Aspartate aminotransferase increased
Blood alkaline phosphatase increased
Blood creatinine increased
Blood immunoglobulin g decreased
Blood magnesium decreased
Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Haematocrit decreased

40-49:

Diarrhoea
Headache (pain in head)

50-59:

Diarrhoea

60+:

Sialoadenitis (inflammation of a salivary gland)
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Decreased appetite
Dehydration (dryness resulting from the removal of water)
Drug hypersensitivity
Dysphagia (a condition in which swallowing is difficult or painful)
Epistaxis (bleed from the nose)
Rash
Stomatitis (inflammation of mucous membrane of mouth)
Upper-airway cough syndrome

What are the existing conditions these people have? *

Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 13 people, 38.24%
Chronic Graft Versus Host Disease (immune cells attack the host's body cells after transplant): 12 people, 35.29%
Dry Skin: 3 people, 8.82%
Graft Versus Host Disease In Skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin): 2 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Rezurock and Zofran?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously